Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“ Ayurcann ” or the “ Company ”) is excited to announce record-breaking financial results for the three months ended December 31, 2024, the highlights of which are included in this news release. As a leading player in the rapidly growing cannabis industry, Ayurcann continues to demonstrate exceptional growth and operational... Read More

Toronto, Ontario, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. ( CSE: AYUR , OTCQB: AYURF ) (“ Ayurcann ” or the “ Company ”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce its financial and operational results for the three months ended September 30, 2024, the highlights of which are included in this news release. All figures are... Read More

Toronto, Ontario, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announces that, further to its press releases dated June 27, 2024 (the “ June 27 Release ”) and November 20, 2024, it has sent a letter to Arogo Capital Acquisition Corporation (“ Arogo ”)... Read More

Toronto, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announces that, further to its press release date June 27, 2024 (the “ June 27 Release ”), it has received correspondence from Arogo Capital Acquisition Corporation that the... Read More

Toronto, Ontario, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce its financial and operational results for the year ended June 30, 2024, the highlights of which are included in this news release. All figures are reported in... Read More

Ayurcann is an award-winning Canadian cannabis extraction company that specializes in the processing and manufacturing of cannabis 2.0 and 3.0 products: Ayurcann is the #1 producer of vapes in Ontario 1 , and Top 5 pre-roll manufacturer by volume in Ontario as of March 30, 2024 2 . The revenue in the Canadian cannabis market is projected to reach US$5.63bn in 2024 and is expected to show an annual growth rate in the years... Read More

Toronto, Ontario, May 27, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. ( CSE: AYUR , OTCQB: AYURF , FSE: 3ZQ0 ) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three and nine months ended March 31, 2024, the... Read More

Toronto, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. ( CSE: AYUR , OTCQB: AYURF , FSE: 3ZQ0 ) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various derivative cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three and six months ended December... Read More

Pickering, Ontario, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. ( CSE: AYUR , OTCQB: AYURF , FSE: 3ZQ0 ) (“ Ayurcann ” or the “ Company ”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is please to announce the following... Read More

Toronto, Ontario, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company, specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to provide the following corporate... Read More

Toronto, Ontario, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. ( CSE: AYUR , OTCQB: AYURF , FSE: 3ZQ0 ) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various derivative cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three-months ended September 30,... Read More

Toronto, Ontario, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. ( CSE: AYUR , OTCQB: AYURF , FSE: 3ZQ0 ) (“ Ayurcann ” or the “ Company ”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to announce its financial and... Read More

Toronto, Ontario, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. ( CSE: AYUR , OTCQB: AYURF , FSE: 3ZQ0 ) (“ Ayurcann ” or the “ Company ”), a leading Canadian cannabis company specializing in the processing and manufacturing of cannabis 2.0 and 3.0 products in the recreational market, is pleased to provide a corporate update to its operations. OPERATIONAL HIGHLIGHTS: Successfully grew product offerings to 60... Read More

Toronto, Ontario, May 29, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis company specializing in the processing and manufacturing of cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three- and nine-months ended March 31, 2023, the highlights of which... Read More

Toronto, Ontario, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. ( CSE: AYUR , OTCQB: AYURF , FSE: 3ZQ0 ) (“ Ayurcann ” or the “ Company ”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational... Read More

Ayurcann Holdings Corp. ( CSE: AYUR ) ( OTCQB: AYURF) (FSE: 3ZQ0 ) (" Ayurcann " or the " Company "), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to announce that, further to its press release dated June 22, 2022, the Company... Read More

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) (FSE: 3ZQ0) (" Ayurcann " or the " Company "), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to provide a corporate update and growth strategy in recreational cannabis in Canada.... Read More

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) (FSE: 3ZQ0) (" Ayurcann " or the " Company "), an established cannabis extraction and manufacturing company, is pleased to announce, in furtherance to their press release dated April 6, 2022 , that the Company is taking another step towards solidifying itself as a major player in the post-harvest solution space within the Canadian Cannabis industry, by entering into a share... Read More

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) (FSE: 3ZQ0) (" Ayurcann " or the " Company "), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational markets, is pleased to report its financial and operating results for the three and nine-months ended... Read More

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) (FSE: 3ZQ0) (" Ayurcann " or the " Corporation "), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to announce that it has received its flower sales license amendment from Health... Read More

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) (FSE: 3ZQ0) (" Ayurcann " or the " Corporation "), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational... Read More

Production Increase and Market Growth in Recreational Cannabis Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) (FSE: 3ZQ0) (" Ayurcann " or the " Corporation "), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative... Read More